Alps Advisors Inc Karyopharm Therapeutics Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.81 $717 - $1,138	629 Added 0.75%	84,432 $113,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $150,007 - $384,655	83,803 New	83,803 $150,000
Q4 2020 Feb 03, 2021	SELL	$14.15 - $17.19 $1.33 Million - $1.61 Million	-93,706 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$14.14 - $19.71 $85,448 - $119,107	-6,043 Reduced 6.06%	93,706 $1.37 Million
Q2 2020 Aug 05, 2020	BUY	$16.6 - $25.25 $1.66 Million - $2.52 Million	99,749 New	99,749 $1.89 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.